Global Cancer Supportive Care Drugs Market Size study & Forecast, by Type by Application, by Distribution Channel and Regional Analysis, 2023-2030

Description

List of Tables

Global Cancer Supportive Care Drugs Market is valued at approximately USD 20.50 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.2% over the forecast period 2023-2030. Cancer supportive care drugs, also known as palliative care drugs, are medications used to manage the symptoms and side effects of cancer and its treatments. These drugs are designed to improve the quality of life for cancer patients by alleviating pain, reducing treatment-related complications, and addressing various physical and emotional challenges that arise during the disease. The Cancer Supportive Care Drugs Market is expanding because of factors such as the rising prevalence of cancer, and rising government funding for drug development.

The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is 27.5 million new cases by 2040 from 1.9 million new cases in year 2021.Furthermore, increasing disposable income as well as improved healthcare structure has also helped people to access cancer supportive care drugs, which is also helping this market grow. For instance, according to an update from August 2021, MediShield Life coverage in Singapore went from paying USD 3,000 per month to a range of USD 200 to USD 9,600 per month, depending on the medications used. Along with increasing the eligibility requirements for Medication Assistance Fund subsidies for some expensive medications from USD 2,800 to USD 6,500, the government would also subsidize more cancer treatments. In addition, the increase in R&D and several pipeline cancer supportive care drugs and the surge in the global geriatric population are creating lucrative growth in the market. However, the high cost of Cancer Supportive Care Drugs stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cancer Supportive Care Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market player, rising prevelance of cancer disease in the region, and rising development of new cancer drugs in the region. Asia Pacific is expected to grow at a fastest rate during the forecast period, owing to factors such as rising prevelance of cancer, rising funding and investment on research and development activities and rising government support to the industry.

Major market player included in this report are:

Amgen Inc.
Baxter International Inc.
F Hoffmann-La Roche Ltd.
Glaxosmithkline Plc (Gsk) (Tesasro)
Heron Therapeutics Inc
Johnson & Johnson (Janssen Global Services, Llc,)
Merck Kgaa
Novartis International Ag (Sandoz)
Teva Pharmaceuticals Industries Ltd
Helsinn Healthcare SA

Recent Developments in the Market:

In March 2022, Australian-based Imugene announced a new clinical trial partnership and supply agreement with MSD, a brand name of Merck & Co., Inc., Kenilworth, NJ, USA, to test the safety and effectiveness of Imugene's HER-Vaxx, a B-cell activating immunotherapy, in combination with MSD's anti-PD-1 therapy, pembrolizumab (KEYTRUDA), in patients with HER-2 positive gastric cancer.
In March 2022, Pluvicto from Novartis has been authorised by the US Food and Drug Administration (FDA) to treat people with this specific cancer type. These patients have already had androgen receptor pathway inhibition and taxane-based chemotherapy.

Global Cancer Supportive Care Drugs Market Report Scope:

Historical Data: 2020 - 2021
Base Year for Estimation: 2022
Forecast period: 2023-2030
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Type, Application, Distribution Channel, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

ESA (Erythropoiesis-Stimulating Agents)
G-CSFs (Granulocyte Colony-Stimulating Factors)
Antiemetics
Bisphosphonates
Opioids
NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
Others

By Application:

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Stomach Cancer
Others

By Distribution Channel:

Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Providers

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Cancer Supportive Care Drugs Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Cancer Supportive Care Drugs Market, by Type, 2020-2030 (USD Billion)
- 1.2.3. Cancer Supportive Care Drugs Market, by Application, 2020-2030 (USD Billion)
- 1.2.4. Cancer Supportive Care Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Cancer Supportive Care Drugs Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Cancer Supportive Care Drugs Market Dynamics

3.1. Cancer Supportive Care Drugs Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidence of cancer
  - 3.1.1.2. Rising government funding for drugs development
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Cancer Supportive Care Drugs
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increase in R&D and number of pipeline cancer supportive care drugs
  - 3.1.3.2. Surge in global geriatric population

Chapter 4. Global Cancer Supportive Care Drugs Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Supportive Care Drugs Market, by Type

5.1. Market Snapshot
5.2. Global Cancer Supportive Care Drugs Market by Type, Performance - Potential Analysis
5.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
- 5.4.1. ESA (Erythropoiesis-Stimulating Agents)
- 5.4.2. ESA (Erythropoiesis-Stimulating Agents)
- 5.4.3. G-CSFs (Granulocyte Colony-Stimulating Factors)
- 5.4.4. Antiemetics
- 5.4.5. Bisphosphonates
- 5.4.6. Opioids
- 5.4.7. NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
- 5.4.8. Others
- 5.4.9.

Chapter 6. Global Cancer Supportive Care Drugs Market, by Application

6.1. Market Snapshot
6.2. Global Cancer Supportive Care Drugs Market by Application, Performance - Potential Analysis
6.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
- 6.4.1. Breast Cancer
- 6.4.2. Lung Cancer
- 6.4.3. Colorectal Cancer
- 6.4.4. Prostate Cancer
- 6.4.5. Liver Cancer
- 6.4.6. Stomach Cancer
- 6.4.7. Others

Chapter 7. Global Cancer Supportive Care Drugs Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Cancer Supportive Care Drugs Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
- 7.4.1. Hospital Pharmacies
- 7.4.2. Drug Stores and Retail Pharmacies
- 7.4.3. Online Providers

Chapter 8. Global Cancer Supportive Care Drugs Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Cancer Supportive Care Drugs Market, Regional Market Snapshot
8.4. North America Cancer Supportive Care Drugs Market
- 8.4.1. U.S. Cancer Supportive Care Drugs Market
  - 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Cancer Supportive Care Drugs Market
8.5. Europe Cancer Supportive Care Drugs Market Snapshot
- 8.5.1. U.K. Cancer Supportive Care Drugs Market
- 8.5.2. Germany Cancer Supportive Care Drugs Market
- 8.5.3. France Cancer Supportive Care Drugs Market
- 8.5.4. Spain Cancer Supportive Care Drugs Market
- 8.5.5. Italy Cancer Supportive Care Drugs Market
- 8.5.6. Rest of Europe Cancer Supportive Care Drugs Market
8.6. Asia-Pacific Cancer Supportive Care Drugs Market Snapshot
- 8.6.1. China Cancer Supportive Care Drugs Market
- 8.6.2. India Cancer Supportive Care Drugs Market
- 8.6.3. Japan Cancer Supportive Care Drugs Market
- 8.6.4. Australia Cancer Supportive Care Drugs Market
- 8.6.5. South Korea Cancer Supportive Care Drugs Market
- 8.6.6. Rest of Asia Pacific Cancer Supportive Care Drugs Market
8.7. Latin America Cancer Supportive Care Drugs Market Snapshot
- 8.7.1. Brazil Cancer Supportive Care Drugs Market
- 8.7.2. Mexico Cancer Supportive Care Drugs Market
8.8. Middle East & Africa Cancer Supportive Care Drugs Market
- 8.8.1. Saudi Arabia Cancer Supportive Care Drugs Market
- 8.8.2. South Africa Cancer Supportive Care Drugs Market
- 8.8.3. Rest of Middle East & Africa Cancer Supportive Care Drugs Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Amgen Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Baxter International Inc.
- 9.3.3. F Hoffmann-La Roche Ltd.
- 9.3.4. Glaxosmithkline Plc (Gsk) (Tesasro)
- 9.3.5. Heron Therapeutics Inc
- 9.3.6. Johnson & Johnson (Janssen Global Services, Llc,)
- 9.3.7. Merck Kgaa
- 9.3.8. Novartis International Ag (Sandoz)
- 9.3.9. Teva Pharmaceuticals Industries Ltd
- 9.3.10. Helsinn Healthcare SA

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Cancer Supportive Care Drugs Market, report scope
TABLE 2. Global Cancer Supportive Care Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Cancer Supportive Care Drugs Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Cancer Supportive Care Drugs Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Cancer Supportive Care Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Cancer Supportive Care Drugs Market
TABLE 71. List of primary sources, used in the study of global Cancer Supportive Care Drugs Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Cancer Supportive Care Drugs Market, research methodology
FIG 2. Global Cancer Supportive Care Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Cancer Supportive Care Drugs Market, key trends 2022
FIG 5. Global Cancer Supportive Care Drugs Market, growth prospects 2023-2030
FIG 6. Global Cancer Supportive Care Drugs Market, porters 5 force model
FIG 7. Global Cancer Supportive Care Drugs Market, pest analysis
FIG 8. Global Cancer Supportive Care Drugs Market, value chain analysis
FIG 9. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Cancer Supportive Care Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)